Tech Company Financing Transactions
Cylene Pharmaceuticals Funding Round
Cylene Pharmaceuticals closed a funding round on 3/31/2009. Backers included BioVentures Investors.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
BioVentures Investors (Peter Feinstein)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5820 Nancy Ridge Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Cylene Pharmaceuticalsdiscovers, develops and commercializessmall molecule drugs that target nucleolus and kill cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Rice
Co-Founder
Daniel Hoff
VP - Bus. Development
Sean O'Brien
VP - Regulatory Affairs
John Lim
Browse more venture capital transactions:
Prev: 3/31/2009: Inogen venture capital transaction
Next: 3/31/2009: Network Vision venture capital transaction
Share this article
Where The Data Comes From
We record funding rounds that are announced publicly. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs